Tumor Protein Content
Tumor Protein Content - Related Videos
10:04
Enhancing Tumor Content through Tumor Macrodissection
0 Views •
Cited by 5 •
2022
This protocol presents a method to increase the percent tumor content of formalin-fixed paraffin-embedded tissue samples.
05:09
Soluble Protein Assay to Quantify Soluble Protein Content in Plant Tissues
0 Views •
2025
This video describes a colorimetric method to quantify the soluble protein content in plant tissues. The method uses Coomassie Brilliant Blue G-250 dye, which interacts with the soluble protein to form a blue-colored stable protein-dye complex, proportional to the soluble protein content in the tissue.
06:44
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
0 Views •
Cited by 2 •
2021
Digital annotation with automated tissue dissection provides an innovative approach to enriching tumor in low tumor content cases and is adaptable to both paraffin and frozen tissue types. The described workflow improves accuracy, reproducibility and throughput and could be applied to both research and clinical settings.
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
0 Views •
Cited by 27 •
2011
Here we describe a method to quantify molecular heterogeneity in histological sections of tumor material using quantitative immunofluorescence, image analysis, and a statistical measure of heterogeneity. The method is intended for use in clinical biomarker development and analysis.
15:04
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
0 Views •
Cited by 46 •
2009
This article describes a novel protocol and reagent set designed for sensitive measurement of neurotoxic effects of compounds and treatments on co-cultures of neurons and astrocytes using high content analysis. Results demonstrate that high content analysis represents an exciting novel technology for neurotoxicity assessment.
FAQs
Tumor protein content changes as a result of coordinated differences in gene expression, protein synthesis, degradation, and signaling activity. Examining both the amount and composition of proteins can therefore reveal whether tumor cells are producing, removing, or regulating molecular components differently. This information exposes biological changes that cellular structure alone may not show.
Protein composition can distinguish tumors by revealing altered molecular pathways that are not evident from cellular structure alone. Differences in the proteins present may also identify molecular markers associated with tumor growth or treatment response. Consequently, protein analysis adds a molecular layer to tumor characterization and can support more precise disease classification.
Biochemical assays, immunostaining, and proteomic analysis provide different ways to examine protein amount and composition in tissue samples. These approaches allow investigators to connect measured protein patterns with altered pathways, tumor classification, and treatment-response research. Selecting among them helps align the analysis with whether the study emphasizes protein quantity, composition, or molecular characterization.
In neuroscience, protein analysis is relevant because brain and central nervous system tumors can display molecular changes linked to tumor development. Assessing their protein patterns may help characterize altered pathways, distinguish tumor types, and identify markers associated with growth or treatment response. These findings support a more molecular understanding of tumors affecting the nervous system.
The process begins with tumor tissue samples, followed by measurement through a biochemical assay, immunostaining, or proteomic analysis. Researchers then interpret the resulting information in relation to protein amount or composition, altered pathways, tumor type, growth, or treatment response. This connects laboratory measurements with questions about tumor biology and classification.
Protein measurements can contribute to disease classification by identifying molecular differences between tumor types. They may also reveal markers associated with tumor growth or treatment response, creating a basis for investigating targeted diagnostic and therapeutic strategies. In this way, protein analysis links tumor biology research with efforts to improve how tumors are recognized and addressed.